BioIVT acquires BeCytes Biotechnologies to boost preclinical research in Europe 11/12/2025 Corporate The U.S. multinational BioIVT, a global leader in the development of high-quality biological samples and research... Partners - Parc Científic de Barcelona
MedTech Barcelona: Highlights and Milestones of 2025 10/12/2025 Access to innovation Corporate New Product Launches: Custom Cell Plates & Shipping Media Partners - MedTech Barcelona
A pivotal year for PVpharm, which, in addition to its pharmacovigilance and clinical safet... 09/12/2025 Healthcare Corporate Among the most notable milestones are the sponsorship of the first edition of the Pharmacovigilance Forum, which... Partners - PVpharm
Integra Therapeuticsappoints Miles Gerson as Independent Chairman 04/12/2025 Corporate Integra Therapeutics strengthens its corporate governance with the appointment of Miles Gerson as Independent Chair of... Partners - Integra Therapeutics S.L.
#NewAseBioMember | " AseBio represents a space that raises the collective bar: being a mem... 03/12/2025 Healthcare Corporate Meet BePharma Institute, our new memeber. We spoke with Pedro Gonzáles Sánchez, manager. Partners - BEPHARMA INSTITUTE
#NewAseBioMember | "AseBio is the meeting point of the Spanish biotechnology ecosystem" 02/12/2025 Healthcare Corporate Meet Neural Omega, our new member. We spoke with Pedro Bernardo Martín-Borregon, Founder & CEO. AseBio - NEURAL OMEGA
Joan Puig: "In inorganic growth in Europe, cultural difference is one of the most importan... 27/11/2025 Healthcare Corporate Joan Puig, a graduate in Pharmacy and in Business Administration and Management, and with a General Management Programme... Partners - GENESIS Biomed
#NewAseBioMember | "AseBio is a meeting point for the sector and a platform for the Spanis... 06/11/2025 Healthcare Corporate Meet our new member Cencora Pharmalex. We spoke with Gonzalo Casino Fernández, Director General Cencora Pharmalex Iberia... AseBio - PHARMALEZ SPAIN S.L.U
ORYZON to participate in upcoming events in November 30/10/2025 Corporate Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that... Partners - Oryzon Genomics
Public research at the Barcelona Science Park – UB reaches a record investment of €84 mill... 28/10/2025 Corporate The public research ecosystem of the Barcelona Science Park (PCB-UB) continues to expand, achieving 84.6 million euros... Partners - Parc Científic de Barcelona
